title: Human Adipose Stromal Cells Increase Survival and Mesenteric Perfusion Following Intestinal Ischemia and Reperfusion Injury.
abstract: Intestinal ischemia can quickly escalate to bowel necrosis and perforation. Transplantation of stem cells presents a novel treatment modality for this problem. We hypothesized that: human adipose-derived stromal cells (hASCs) would increase survival and mesenteric perfusion to a greater degree compared with differentiated cellular controls following ischemic intestinal injury, and improved outcomes with hASC therapy would be associated with preservation of intestinal histological and tight junction architecture, and lower levels of systemic inflammation following intestinal injury.
  
  
  
  hASCs and keratinocytes (differentiated cellular control) were cultured on polystyrene flasks at 37°C in 5% CO2 in air. Adult male C57Bl6J mice were anesthetized and a midline laparotomy performed. The intestines were eviscerated, the small bowel mesenteric root identified, and intestinal ischemia was established by temporarily occluding the superior mesenteric artery for 60 min with a noncrushing vascular clamp. Following ischemia, the clamp was removed, and the intestines were returned to the abdominal cavity. Before abdominal closure, 2 million hASCs or keratinocytes in 250 μL of phosphate-buffered saline (carrier for cells and control solution) were infused into the peritoneum. Animals were allowed to recover for 12 or 24 h (perfusion, histology, cytokine, and immunofluoresence studies), or 7 days (survival studies). Intestinal perfusion was assessed by laser Doppler imaging. Intestinal tissue segments were stained with hematoxylin and eosin, as well as antibodies for the tight junction protein claudin-1. Separate aliquots of intestine, liver, and lung tissue were homogenized and assessed for inflammatory cytokines via multiplex beaded assay.
  
  
  
  Animals administered hASCs following intestinal ischemia and reperfusion (I/R) injury had significantly greater 7-day survival and better postischemic recovery of mesenteric perfusion compared with vehicle or keratinocyte therapy. hASCs also abated intestinal mucosal destruction, facilitated preservation of intestinal tight junctions, and decreased the systemic inflammatory response to injury.
  
  
  
  Human adipose-derived stromal cells improved survival and mesenteric perfusion and attenuated the mucosal damage associated with intestinal I/R injury. hASCs should be considered as a plausible cell source for novel cellular treatment plans following intestinal ischemia.
authors.affiliation: *Department of Surgery †Section of Pediatric Surgery ‡Department of Cellular and Integrative Physiology §Department of Medicine, Indiana Center for Vascular Biology and Medicine ¶Department of Pediatrics, Section of Neonatology ||Riley Hospital for Children at Indiana University Health #Indiana University School of Medicine, Indianapolis, Indiana.
authors.forename: Amanda R
authors.initials: AR
authors.lastname: Jensen
authors.forename: Dominique L
authors.initials: DL
authors.lastname: Doster
authors.forename: E Bailey
authors.initials: EB
authors.lastname: Hunsberger
authors.forename: Morenci M
authors.initials: MM
authors.lastname: Manning
authors.forename: Samantha M
authors.initials: SM
authors.lastname: Stokes
authors.forename: Daria
authors.initials: D
authors.lastname: Barwinska
authors.forename: Keith L
authors.initials: KL
authors.lastname: March
authors.forename: Mervin C
authors.initials: MC
authors.lastname: Yoder
authors.forename: Troy A
authors.initials: TA
authors.lastname: Markel
mesh_terms: D000273:Adipose Tissue / Q000166:cytology*; D000818:Animals; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000628:therapy; D007410:Intestinal Diseases / Q000276:immunology / Q000628:therapy*; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008297:Male; D008638:Mesenteric Arteries / Q000473:pathology / Q000502:physiology; D008810:Mice, Inbred C57BL; D015427:Reperfusion Injury / Q000276:immunology / Q000628:therapy*; D017154:Stromal Cells / Q000502:physiology* / Q000637:transplantation